厄多司坦治疗老年支气管扩张症及黏液分泌过多患者的效果

发布时间：2018-04-21 13:46

本文选题：支气管扩张症 + 黏液分泌　；参考：《中国老年学杂志》2015年14期

【摘要】：目的探讨厄多司坦对老年支气管扩张症及黏液分泌过多患者的治疗效果。方法选择2012年1月到2013年12月的80例确为支气管扩张症及黏液分泌过多的老年患者。随机均分成观察组和对照组各40例。对照组采用非药物性气道清理的物理方法方法进行治疗。观察组在对照组的治疗基础上加服厄多司坦。结果两组患者在治疗前各项相关指标比较均无显著差异(P0.05);两组患者在治疗后的VAS、PEF、Pa CO2指标比治疗前有显著改善,且观察组的改善程度优于对照组(P0.05)。两组患者在治疗前痰液性状变化比均无显著差异(P0.05);治疗后的MD、MP、MVP评分均有显著性差异(P0.05)。结论采用厄多司坦治疗老年支气管扩张症及黏液分泌过多患者,能有效减少并发症,增加治愈率,降低不良反应发生率,效果良好,适用临床推广。
[Abstract]:Objective to investigate the therapeutic effect of erdostam on senile bronchiectasis and mucus hypersecretion. Methods from January 2012 to December 2013, 80 elderly patients with bronchiectasis and excessive mucus secretion were selected. They were randomly divided into observation group (n = 40) and control group (n = 40). The control group was treated by physical method of non-drug airway cleaning. The observation group was treated with erdostam on the basis of the treatment of the control group. Results there was no significant difference in the relative indexes before treatment between the two groups, and the CO2 index of the two groups was significantly improved after treatment, and the improvement degree of the observation group was better than that of the control group (P 0.05). There was no significant difference in sputum characteristics between the two groups before and after treatment (P 0.05), and there was significant difference in MVP scores of MPN after treatment (P 0.05). Conclusion the treatment of bronchiectasis and excessive mucus secretion with erdostam can effectively reduce the complications, increase the cure rate and decrease the incidence of adverse reactions. It is suitable for clinical application.
【作者单位】：抚州市第一人民医院ICU;
【分类号】：R562.22

【参考文献】